TP53 Y220C is a hotspot mutation in oropharyngeal squamous cell carcinoma

Pathobiology

Volumn 82, Issue 1, 2015, Pages 21-27

  Van Kempen, Pauline M W ^a   Verdam, Froukje J ^a   De Poel, Eyleen ^a   Braunius, Weibel W ^a   De Weger, Roel A ^a   Van Es, Robert J J ^a   Grolman, Wilko ^a   Willems, Stefan M ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Head and neck cancer; Oropharyngeal squamous cell carcinoma; TP53; Y220C mutation

Indexed keywords

ARGININE; ASPARTIC ACID; CYSTEINE; GLUTAMIC ACID; GLYCINE; HISTIDINE; LEUCINE; LYSINE; PHENYLALANINE; PROTEIN P53; SERINE; TRYPTOPHAN; TYROSINE; VALINE;

ADULT; AGED; ALCOHOL CONSUMPTION; AMINO ACID SUBSTITUTION; ARTICLE; CANCER LOCALIZATION; CANCER SURVIVAL; CODON; ESOPHAGUS; EXON; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; HYPOPHARYNX; INDEL MUTATION; LARYNX; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; MOUTH CAVITY; MUTATION RATE; MUTATIONAL ANALYSIS; OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; OROPHARYNX; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SMOKING;

EID: 84924692359     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000369102     Document Type: Article

References (38)

1. Leemans CR, Braakhuis BJ, Brakenhoff RH: The molecular biology of head and neck cancer. Nat Rev Cancer 2011; 11: 9-22.
2. Belbin TJ, Schlecht NF, Smith RV, Adrien LR, Kawachi N, Brandwein-Gensler M, Bergman A, Chen Q, Childs G, Prystowsky MB: Sitespecific molecular signatures predict aggressive disease in HNSCC. Head Neck Pathol 2008; 2: 243-256.
3. Smith EM, Rubenstein LM, Haugen TH, Hamsikova E, Turek LP: Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers. Cancer Causes Control 2010; 21: 1369-1378.
4. Warnakulasuriya S: Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009; 45: 309-316.
5. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C, et al: Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
6. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML: Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-269.
7. Greenblatt MS, Bennett WP, Hollstein M, Harris CC: Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-4878.
8. Ko LJ, Prives C: p53: puzzle and paradigm. Genes Dev 1996; 10: 1054-1072.
9. Resnick MA, Inga A: Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity. Proc Natl Acad Sci U S A 2003; 100: 9934-9939.
10. Freed-Pastor WA, Prives C: Mutant p53: one name, many proteins. Genes Dev 2012; 26: 1268-1286.
11. Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, Bronson RT, Crowley D, Jacks T: Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 2004; 119: 847-860.
12. Brosh R, Rotter V: When mutants gain new powers: News from the mutant p53 field. Nat Rev Cancer 2009; 9: 701-713.
13. Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
14. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A, et al: The mutational landscape of head and neck squamous cell carcinoma. Science 2011; 333: 1157-1160.
15. Chung CH, Gillison ML: Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res 2009; 15: 6758-6762.
16. Ruttkay-Nedecky B, Jimenez Jimenez AM, Nejdl L, Chudobova D, Gumulec J, Masarik M, Adam V, Kizek R: Relevance of infection with human papillomavirus: the role of the p53 tumor suppressor protein and E6/E7 zinc finger proteins (review). Int J Oncol 2013; 43: 1754-1762.
17. Kimple RJ, Smith MA, Blitzer GC, Torres AD, Martin JA, Yang RZ, Peet CR, Lorenz LD, Nickel KP, Klingelhutz AJ, et al: Enhanced radiation sensitivity in HPV-positive head and neck cancer. Cancer Res 2013; 73: 4791-4800.
18. Brennan JA, Boyle JO, Koch WM, Goodman SN, Hruban RH, Eby YJ, Couch MJ, Forastiere AA, Sidransky D: Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 1995; 332: 712-717.
19. Somers KD, Merrick MA, Lopez ME, Incognito LS, Schechter GL, Casey G: Frequent p53 mutations in head and neck cancer. Cancer Res 1992; 52: 5997-6000.
20. Sidransky D, Hollstein M: Clinical implications of the p53 gene. Annu Rev Med 1996; 47: 285-301.
21. Nagai MA, Miracca EC, Yamamoto L, Moura RP, Simpson AJ, Kowalski LP, Brentani RR: TP53 genetic alterations in head-and-neck carcinomas from Brazil. Int J Cancer 1998; 76: 13-18.
22. van Diest PJ: No consent should be needed for using leftover body material for scientific purposes. For. BMJ 2002; 325: 648-651.
23. McMahon S, Chen AY: Head and neck cancer. Cancer Metastasis Rev 2003; 22: 21-24.
24. Takes RP, Baatenburg de Jong RJ, Schuuring E, Litvinov SV, Hermans J, Van Krieken JH: Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell. Anticancer Res 1998; 18: 4793-4800.
25. van Kempen PM, Noorlag R, Braunius WW, Stegeman I, Willems SM, Grolman W: Differences in methylation profiles between HPVpositive and HPV-negative oropharynx squamous cell carcinoma: A systematic review. Epigenetics 2014; 9: 194-203.
26. Lleras RA, Smith RV, Adrien LR, Schlecht NF, Burk RD, Harris TM, Childs G, Prystowsky MB, Belbin TJ: Unique DNA methylation loci distinguish anatomic site and HPV status in head and neck squamous cell carcinoma. Clin Cancer Res 2013; 19: 5444-5455.
27. Lasky T, Silbergeld E: P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers. Environ Health Perspect 1996; 104: 1324-1331.
28. Poeta ML, Manola J, Goldwasser MA, Forastiere A, Benoit N, Califano JA, Ridge JA, Goodwin J, Kenady D, Saunders J, et al: TP53 mutations and survival in squamous-cell carcinoma of the head and neck. N Engl J Med 2007; 357: 2552-2561.
29. Hsieh LL, Wang PF, Chen IH, Liao CT, Wang HM, Chen MC, Chang JT, Cheng AJ: Characteristics of mutations in the p53 gene in oral squamous cell carcinoma associated with betel quid chewing and cigarette smoking in Taiwanese. Carcinogenesis 2001; 22: 1497-1503.
30. Munirajan AK, Tutsumi-Ishii Y, Mohanprasad BK, Hirano Y, Munakata N, Shanmugam G, Tsuchida N: p53 gene mutations in oral carcinomas from India. Int J Cancer 1996; 66: 297-300.
31. Norberg T, Klaar S, Karf G, Nordgren H, Holmberg L, Bergh J: Increased p53 mutation frequency during tumor progression-results from a breast cancer cohort. Cancer Res 2001; 61: 8317-8321.
32. Koch WM, Lango M, Sewell D, Zahurak M, Sidransky D: Head and neck cancer in nonsmokers: A distinct clinical and molecular entity. Laryngoscope 1999; 109: 1544-1551.
33. Chung KY, Mukhopadhyay T, Kim J, Casson A, Ro JY, Goepfert H, Hong WK, Roth JA: Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 1993; 53: 1676-1683.
34. Kropveld A, Rozemuller EH, Leppers FG, Scheidel KC, de Weger RA, Koole R, Hordijk GJ, Slootweg PJ, Tilanus MG: Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers. Lab Invest 1999; 79: 347-353.
35. Mao L: A new marker determining clonal outgrowth. Clin Cancer Res 2002; 8: 2021-2023.
36. Riemer AB, Zielinski CC: Use of trastuzumab in the therapy of breast cancer. Ther Umsch 2008; 65: 217-222.
37. Dhomen NS, Mariadason J, Tebbutt N, Scott AM: Therapeutic targeting of the epidermal growth factor receptor in human cancer. Crit Rev Oncog 2012; 17: 31-50.
38. Basse N, Kaar JL, Settanni G, Joerger AC, Rutherford TJ, Fersht AR: Toward the rational design of p53-stabilizing drugs: probing the surface of the oncogenic Y220C mutant. Chem Biol 2010; 17: 46-56.